Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Analyzing BMNR's Positive Market Factors

Series stock is trading -45.05% below its average target price of $53.5 after dropping -5.5% during today's morning session. Analysts are giving the Large-Cap Diversified Financial company an average rating of buy and target prices ranging from $47.0 to $60.0 per share.

Series has an average level of shares sold short, at 9.9% of its total share float. The stock's short ratio (also called days to cover) is 0.69. The company's insiders own 2.7% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 22.5% of Series's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Series

Date Reported Holder Percentage Shares Value
2025-09-30 Morgan Stanley 24% 9,696,703 $285,083,064
2025-09-30 Susquehanna International Group, LLP 19% 7,689,603 $226,074,325
2025-09-30 ARK Investment Management, LLC 18% 7,469,813 $219,612,499
2025-09-30 FMR, LLC 15% 6,025,196 $177,140,760
2025-09-30 Sumitomo Mitsui Trust Group, Inc. 9% 3,784,639 $111,268,385
2025-09-30 Amova Asset Management Americas Inc 9% 3,781,818 $111,185,447
2025-09-30 Blackrock Inc. 8% 3,407,322 $100,175,265
2025-09-30 Jane Street Group, LLC 8% 3,250,699 $95,570,549
2025-09-30 Citadel Advisors Llc 7% 3,005,459 $88,360,493
2025-09-30 Clear Street Group Inc. 7% 2,882,843 $84,755,583
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS